Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Andrews

Showing results (551-560 of 574) with videos related to

Pageof 58
Sort By:
British Journal of Clinical Pharmacology|March 26, 2024
The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records, Christopher Wood, Victoria Speed, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 6, 2023
Development, initial validation, and application of a visual read method for [<sup>18</sup>F]MK-6240 tau PETJoanna L Shuping, Dawn C Matthews, Katarzyna Adamczuk, et al.
Scientific Reports|November 9, 2023
Expanding our view of the cold-water coral niche and accounting of the ecosystem services of the reef habitatErik E Cordes, Amanda W J Demopoulos, Andrew J Davies, et al.
Cell Reports. Medicine|January 14, 2022
Deletions in <i>VANGL1</i> are a risk factor for antibody-mediated kidney diseaseSimon H Jiang, Sevcan Mercan, Ilenia Papa, et al.
The Lancet. Public Health|April 29, 2023
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platformLinda Nab, Edward P K Parker, Colm D Andrews, et al.
Chemmedchem|July 9, 2019
Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular SafetyFrederick Cohen, James B Aggen, Logan D Andrews, et al.
The Journal of Clinical Investigation|February 15, 2024
A metabolic signature for NADSYN1-dependent congenital NAD deficiency disorderJustin O Szot, Hartmut Cuny, Ella Mma Martin, et al.
Nucleic Acids Research|December 19, 2003
Ensembl 2004E Birney, D Andrews, P Bevan, et al.
Pharmacoepidemiology and Drug Safety|May 24, 2024
OpenSAFELY: A platform for analysing electronic health records designed for reproducible researchLinda Nab, Andrea L Schaffer, William Hulme, et al.
BMJ Medicine|March 20, 2023
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELYAmelia C A Green, Helen J Curtis, Rose Higgins, et al.
Pageof 58

Showing results (551-560 of 574) with videos related to

Sort By:
Pageof 58
British Journal of Clinical Pharmacology|March 26, 2024
The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records, Christopher Wood, Victoria Speed, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 6, 2023
Development, initial validation, and application of a visual read method for [<sup>18</sup>F]MK-6240 tau PETJoanna L Shuping, Dawn C Matthews, Katarzyna Adamczuk, et al.
Scientific Reports|November 9, 2023
Expanding our view of the cold-water coral niche and accounting of the ecosystem services of the reef habitatErik E Cordes, Amanda W J Demopoulos, Andrew J Davies, et al.
Cell Reports. Medicine|January 14, 2022
Deletions in <i>VANGL1</i> are a risk factor for antibody-mediated kidney diseaseSimon H Jiang, Sevcan Mercan, Ilenia Papa, et al.
The Lancet. Public Health|April 29, 2023
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platformLinda Nab, Edward P K Parker, Colm D Andrews, et al.
Chemmedchem|July 9, 2019
Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular SafetyFrederick Cohen, James B Aggen, Logan D Andrews, et al.
The Journal of Clinical Investigation|February 15, 2024
A metabolic signature for NADSYN1-dependent congenital NAD deficiency disorderJustin O Szot, Hartmut Cuny, Ella Mma Martin, et al.
Nucleic Acids Research|December 19, 2003
Ensembl 2004E Birney, D Andrews, P Bevan, et al.
Pharmacoepidemiology and Drug Safety|May 24, 2024
OpenSAFELY: A platform for analysing electronic health records designed for reproducible researchLinda Nab, Andrea L Schaffer, William Hulme, et al.
BMJ Medicine|March 20, 2023
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELYAmelia C A Green, Helen J Curtis, Rose Higgins, et al.
Pageof 58